As doctoral students nearly 20 years ago, two Cornell researchers played an early role in the development of the work that was awarded the 2022 Nobel Prize in chemistry.
By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced.
David Reetz, director of counseling and psychological services at the Rochester Institute of Technology, has been named Cornell’s new director of Counseling and Psychological Services; he will join Cornell in mid-December.
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.
A cellular process known as autophagy that helps rid cells of debris may be impaired in pregnant women who go on to develop postpartum depression, according to new research from Weill Cornell Medicine.
The conference sought to unite the public and private sectors around a coordinated strategy to drive change in the U.S. to end hunger, and improve nutrition and physical activity.
Reginald M. Ballantyne III, MBA ’67 is a prominent health care industry leader and longtime supporter of Cornell programs. He has endowed a scholarship that is the largest gift in the history of the Sloan Program in Health Administration in the Cornell Jeb E. Brooks School of Public Policy.
